Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 SPRB stock ended at $0.85. This is 5.75% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 7.98% from a day low at $0.784 to a day high of $0.85.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Spruce Biosciences, Inc. prices

Date Open High Low Close Volume
May 08, 2024 $0.785 $0.85 $0.784 $0.85 719 782
May 07, 2024 $0.738 $0.80 $0.731 $0.800 648 526
May 06, 2024 $0.750 $0.756 $0.725 $0.754 335 938
May 03, 2024 $0.755 $0.756 $0.733 $0.744 502 723
May 02, 2024 $0.730 $0.750 $0.721 $0.742 278 881
May 01, 2024 $0.730 $0.751 $0.712 $0.717 747 686
Apr 30, 2024 $0.700 $0.719 $0.700 $0.708 234 911
Apr 29, 2024 $0.707 $0.715 $0.698 $0.710 252 243
Apr 26, 2024 $0.710 $0.710 $0.698 $0.700 194 678
Apr 25, 2024 $0.680 $0.710 $0.680 $0.701 376 736
Apr 24, 2024 $0.690 $0.713 $0.689 $0.702 416 900
Apr 23, 2024 $0.696 $0.749 $0.696 $0.701 1 022 240
Apr 22, 2024 $0.680 $0.703 $0.671 $0.692 388 989
Apr 19, 2024 $0.700 $0.711 $0.687 $0.700 627 030
Apr 18, 2024 $0.693 $0.716 $0.693 $0.701 285 153
Apr 17, 2024 $0.693 $0.740 $0.693 $0.706 691 305
Apr 16, 2024 $0.690 $0.738 $0.687 $0.700 859 347
Apr 15, 2024 $0.740 $0.740 $0.683 $0.706 1 272 668
Apr 12, 2024 $0.773 $0.773 $0.731 $0.736 512 776
Apr 11, 2024 $0.750 $0.775 $0.741 $0.764 412 514
Apr 10, 2024 $0.780 $0.780 $0.739 $0.750 726 052
Apr 09, 2024 $0.790 $0.790 $0.754 $0.768 615 919
Apr 08, 2024 $0.83 $0.83 $0.790 $0.790 626 929
Apr 05, 2024 $0.83 $0.85 $0.82 $0.84 243 750
Apr 04, 2024 $0.81 $0.87 $0.80 $0.84 1 115 596
Click to get the best stock tips daily for free!

About Spruce Biosciences, Inc.

Spruce Biosciences. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adu... SPRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT